60 Degrees Pharmaceuticals Inc. (SXTP) Reports Q3 Loss, Misses Revenue Estimates
Portfolio Pulse from
60 Degrees Pharmaceuticals Inc. (SXTP) reported a Q3 loss of $0.93 per share, missing the Zacks Consensus Estimate of a $0.60 loss. This is an improvement from the $3.60 loss per share a year ago.
November 14, 2024 | 9:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
60 Degrees Pharmaceuticals Inc. (SXTP) reported a Q3 loss of $0.93 per share, missing the Zacks Consensus Estimate of a $0.60 loss. Despite missing estimates, the loss is an improvement from the previous year's $3.60 per share.
The reported loss per share of $0.93 is worse than the expected $0.60, which is likely to negatively impact the stock price in the short term. However, the improvement from last year's $3.60 loss per share may provide some positive sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100